117.06
Irhythm Holdings Inc stock is traded at $117.06, with a volume of 464.72K.
It is down -7.88% in the last 24 hours and up +5.05% over the past month.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$126.44
Open:
$124.85
24h Volume:
464.72K
Relative Volume:
0.77
Market Cap:
$3.86B
Revenue:
$787.85M
Net Income/Loss:
$-27.78M
P/E Ratio:
-134.93
EPS:
-0.8676
Net Cash Flow:
$18.75M
1W Performance:
-6.66%
1M Performance:
+5.05%
6M Performance:
-21.47%
1Y Performance:
-27.47%
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IRTC
Irhythm Holdings Inc
|
117.17 | 4.17B | 787.85M | -27.78M | 18.75M | -0.8676 |
|
ABT
Abbott Laboratories
|
110.11 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
332.33 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
90.67 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
51.55 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
90.83 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
iRhythm Technologies (NASDAQ:IRTC) Stock Price Down 6%Here's Why - marketbeat.com
iRhythm Holdings (IRTC) Stock Analysis: A 39.87% Upside Opportunity in the Medical Device Sector - DirectorsTalk Interviews
The Top 5 Analyst Questions From iRhythm’s Q2 Earnings Call - Yahoo! Finance Canada
iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform - Zacks Investment Research
RTW Investments (IRTC) discloses 6.6% iRhythm stake via 2.18M shares - Stock Titan
Assenagon Asset Management S.A. Sells 248,060 Shares of iRhythm Technologies $IRTC - marketbeat.com
Brian Yoor Steps Down from iRhythm Holdings Board; Karen McGinnis Named Audit Committee Chair - Kalkine Media
Artisan Partners group (IRTC) discloses 5.1% iRhythm Holdings position - Stock Titan
IRhythm Holdings, Inc. Announces Board and Committee Changes, Effective August 12, 2026 - marketscreener.com
Why iRhythm (IRTC) Shares Are Trading Lower Today - Yahoo Finance
Deals tracker: MaineHealth approved to acquire York Hospital - Modern Healthcare
iRhythm Technologies $IRTC Shares Sold by Bank of America Corp DE - marketbeat.com
iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of "Moderate Buy" by Analysts - marketbeat.com
iRhythm Holdings CBO/CLO Patrick Michael Murphy Reports Stock Acquisition and Sale in August 2026 - Kalkine Media
iRhythm CEO Quentin Blackford Reports Vesting of Performance RSUs and Subsequent Share Sale for Tax Obligations - kalkinemedia.com
iRhythm Holdings Executive Chad Patterson Reports RSU Vesting and Tax-Driven Stock Sale - Kalkine Media
iRhythm Holdings (IRTC) CEO sells 26,859 shares after 48,534 RSUs vest - Stock Titan
iRhythm Holdings (IRTC) CBO/CLO nets RSU shares, sells stock for taxes - Stock Titan
iRhythm (IRTC) officer gains RSU shares, sells portion to cover tax - Stock Titan
iRhythm Holdings (IRTC) executive sells shares to cover taxes after RSU vest - Stock Titan
iRhythm (IRTC) CRO Sumi Shrishrimal nets shares after RSU vesting and tax sale - Stock Titan
IRTC Looks 20.5% Undervalued on GF Value™ Despite Short-Seller P - GuruFocus
iRhythm Technologies $IRTC Shares Acquired by Quantinno Capital Management LP - marketbeat.com
Q2 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
iRhythm to Acquire VitalConnect in $287.5 Million Digital Health Deal - Global Legal Chronicle
IRhythm Holdings Is Maintained at Buy by Truist Securities - Moomoo
Why iRhythm (IRTC) Stock Is Trading Up Today - Yahoo Finance
IRTC Maintained by Truist Securities -- Price Target Raised to $168 - GuruFocus
Strategic Consolidation in Cardiac Intelligence: Analysis of iRhythm Holdings’ $287.5 Million Acquisition of VitalConnect - healthcare.digital
iRhythm Technologies (NASDAQ:IRTC) Stock Price Expected to Rise, Truist Financial Analyst Says - marketbeat.com
M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform - hitconsultant.net
IRhythm to Gain From VitalConnect Deal, Rising Margins, Oppenheimer Says - marketscreener.com
iRhythm to Gain From VitalConnect Deal, Rising Margins, Oppenheimer Says - Yahoo Finance
iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised - Yahoo Finance
IRHYTHM HOLDINGS, INC : TRUIST SECURITIES RAISES TARGET PRICE TO $168 FROM $160 - Bitget
IRTC Q2 Deep Dive: Product Portfolio Expansion and Margin Gains Highlight Quarter - Yahoo Finance
iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care - Sahm
Why iRhythm Holdings (IRTC) Is Up 9.1% After Raising 2026 Outlook and Advancing Legal Settlement – And What's Next - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Rating Lowered to "Hold" at Wall Street Zen - marketbeat.com
Irhythm Technologies Announces Acquisition of Vital Connect - theglobeandmail.com
Irhythm Technologies Boosts Outlook, Expands Cardiac Monitoring Platform - The Globe and Mail
iRhythm Holdings Acquiring VitalConnect for $287.5 Million - barrons.com
IRTC Maintains Overweight Rating -- Price Target Lowered to $168 - GuruFocus
iRhythm Holdings, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:IRTC) 2026-08-07 - Seeking Alpha
IRTC Maintained by Needham -- Price Target Lowered to $192 - GuruFocus
IRTC Maintained by Evercore ISI Group -- Price Target Raised to $165 - GuruFocus
iRhythm advances cardiac monitoring provision with $287.5m VitalConnect acquisition - finance.yahoo.com
Truist Securities Adjusts PT on iRhythm Technologies to $168 From $160, Maintains Buy Rating - marketscreener.com
Truist Securities Adjusts iRhythm Technologies PT to $168 From $160, Maintains Buy Rating - marketscreener.com
iRhythm Technologies (NASDAQ:IRTC) Sees Unusually-High Trading Volume Following Strong Earnings - marketbeat.com
iRhythm Holdings, Inc. Stock 12‑Month Price Target Raised to $180.79, Implies 41% Upside - TradingView
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Irhythm Holdings Inc Stock (IRTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Murphy Patrick Michael | CBO and CLO |
Aug 10 '26 |
Sale |
124.65 |
7,093 |
884,156 |
69,699 |
| Patterson Chad | CHIEF COMM & PRODUCT OFFICER |
Aug 10 '26 |
Sale |
124.65 |
7,093 |
884,170 |
62,125 |
| Shrishrimal Sumi | EVP, Chief Risk Officer |
Aug 10 '26 |
Sale |
124.65 |
5,372 |
669,641 |
44,621 |
| Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH |
Aug 10 '26 |
Sale |
124.65 |
7,093 |
884,151 |
60,116 |
| Smith Mervin | EVP Strategic Business Ops |
Aug 03 '26 |
Sale |
122.12 |
617 |
75,349 |
22,410 |
| Rodda Julianne | EVP, CHIEF PEOPLE OFFICER |
Aug 03 '26 |
Sale |
122.12 |
2,112 |
257,919 |
18,201 |
| Patterson Chad | CHIEF COMM & PRODUCT OFFICER |
Aug 03 '26 |
Sale |
122.12 |
2,712 |
331,192 |
55,629 |
| Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH |
Jul 02 '26 |
Sale |
124.71 |
1,423 |
177,462 |
53,620 |
| Freeman Sean Clinton | EVP, Strategy & Corp Devt |
Jul 02 '26 |
Sale |
124.71 |
918 |
114,484 |
13,641 |
| Shrishrimal Sumi | EVP, Chief Risk Officer |
Jun 02 '26 |
Sale |
108.19 |
1,716 |
185,652 |
40,287 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):